The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
LRP and senile plaques in Alzheimer’s disease: colocalization with apolipoprotein E and with activated astrocytes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both the low-density lipoprotein receptor (LDLR) and the LDLR-related protein-1 (LRP-1) may act as A receptors.9 -11”
From Lipoprotein Receptor-Related Protein-1 Mediates Amyloid-β-Mediated Cell Death of Cerebrovascular Cells (2007) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107
Self-citationMa, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
Irizarry, M. C., Soriano, F., McNamara, M., Page, K. J., Schenk, D., Games, D., & Hyman, B. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-18-07053.1997 · Cited by 497
Self-citationInterleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease
Gomez‐Isla, T., West, H. L., Rebeck, G. W., Harr, S. D., Growdon, J. H., Locascio, J. J., Perls, T. T., Lipsitz, L. A., & Hyman, B. T. (1996) · Annals of Neurology · doi:10.1002/ana.410390110 · Cited by 378
Self-citation
Research works printed but not linked: 34
- Abraham, 1988, Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer’s disease, Cell, 52, 487, 10.1016/0092-8674(88)90462-X · DOI · Paper page
- Ard, 1996, Scavenging of Alzheimer’s amyloid beta-protein by microglia in culture, J. Neurosci. Res., 43, 190, 10.1002/(SICI)1097-4547(19960115)43:2<190::AID-JNR7>3.0.CO;2-B · doi:10.1002/(sici)1097-4547(19960115)43:2<190::aid-jnr7>3.0.co;2-b
- Beffert, 1999, Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures, Mol. Brain Res., 68, 181, 10.1016/S0169-328X(99)00073-X · DOI
- Businaro, 1997, Modulation of the alpha 2 macroglobulin receptor/low density lipoprotein receptor related protein by interferon-gamma in human astroglial cells, J. Neuroimmunol., 72, 75, 10.1016/S0165-5728(96)00157-9 · DOI
- Castano, 1995, Fibrillogenesis in Alzheimer’s disease of amyloid beta peptides and apolipoprotein E, Biochem. J., 306, 599, 10.1042/bj3060599 · DOI · Paper page
- Chen, 1998, Neurodegenerative Alzheimer-like pathology in PDAPP 717V→F transgenic mice, Prog. Brain Res., 117, 327, 10.1016/S0079-6123(08)64025-X · DOI
- Cho, 2001, Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation, J. Neuropathol. Exp. Neurol., 60, 342, 10.1093/jnen/60.4.342 · DOI
- Hussaini, 1999, Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes, Glia, 25, 71, 10.1002/(SICI)1098-1136(19990101)25:1<71::AID-GLIA7>3.0.CO;2-0 · DOI
- Hyman, 2000, Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease, Arch. Neurol., 57, 646, 10.1001/archneur.57.5.646 · DOI
- Jordan, 1998, Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures, J. Neurosci., 18, 195, 10.1523/JNEUROSCI.18-01-00195.1998 · DOI · Paper page
- Kounnas, 1992, The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330, J. Biol. Chem., 267, 21162, 10.1016/S0021-9258(19)36811-5 · DOI · Paper page
- Kounnas, 1992, The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A, J. Biol. Chem., 267, 12420, 10.1016/S0021-9258(18)42291-0 · DOI · Paper page
- LaDu, 2001, Apolipoprotein E and apolipoprotein E receptors modulate Abeta-induced glial neuroinflammatory responses, Neurochem. Int., 39, 427, 10.1016/S0197-0186(01)00050-X · DOI · Paper page
- Lynch, 2001, Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response, J. Neuroimmunol., 114, 107, 10.1016/S0165-5728(00)00459-8 · DOI · Paper page
- Marzolo, 2000, Expression of alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells, J. Neurosci. Res., 60, 401, 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.0.CO;2-L · DOI
- Moestrup, 1992, Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues, Cell Tissue Res., 269, 375, 10.1007/BF00353892 · DOI · Paper page
- Namba, 1991, Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt–Jakob disease, Brain Res., 541, 163, 10.1016/0006-8993(91)91092-F · DOI · Paper page
- Paresce, 1996, Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor, Neuron, 17, 553, 10.1016/S0896-6273(00)80187-7 · DOI · Paper page
- Qiu, 1999, Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons, J. Neurochem., 73, 1393, 10.1046/j.1471-4159.1999.0731393.x · DOI · Paper page
- Qiu, 2001, Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer disease and in vitro, J. Neuropathol. Exp. Neurol., 60, 430, 10.1093/jnen/60.5.430 · DOI
- Quinn, 1997, Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma, J. Biol. Chem., 272, 23946, 10.1074/jbc.272.38.23946 · DOI
- Rebeck, 1995, Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein, Ann. Neurol., 37, 211, 10.1002/ana.410370212 · DOI · Paper page
- Schmechel, 1993, Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 9649, 10.1073/pnas.90.20.9649 · DOI · Paper page
- Smith, 1993, Alpha 1-trypsin immunoreactivity in Alzheimer disease, Biochem. Biophys. Res. Commun., 193, 579, 10.1006/bbrc.1993.1663 · DOI
- Strickland, 1990, Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor, J. Biol. Chem., 265, 17401, 10.1016/S0021-9258(18)38172-9 · DOI · Paper page
- Strickland, 1995, LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism, FASEB J., 9, 890, 10.1096/fasebj.9.10.7615159 · DOI · Paper page
- Thal, 1997, The subunits of alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein, native and transformed alpha2-macroglobulin and interleukin 6 in Alzheimer’s disease, Brain Res., 777, 223, 10.1016/S0006-8993(97)01021-4 · DOI
- Tooyama, 1993, Immunohistochemical study of alpha 2 macroglobulin receptor in Alzheimer and control postmortem human brain, Mol. Chem. Neuropathol., 18, 153, 10.1007/BF03160029 · DOI
- Urmoneit, 1997, Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy, Lab. Invest., 77, 157
- Van Gool, 1993, alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer’s disease, Neurobiol. Aging, 14, 233, 10.1016/0197-4580(93)90006-W · DOI
- Winkler, 1999, Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis, J. Lipid Res., 40, 447, 10.1016/S0022-2275(20)32449-4 · DOI
- Wisniewski, 1992, Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosci. Lett., 135, 235, 10.1016/0304-3940(92)90444-C · DOI · Paper page
- Wolf, 1992, Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain, Am. J. Pathol., 141, 37
- Yang, 1999, Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner, Neuroscience, 90, 1217, 10.1016/S0306-4522(98)00561-2 · DOI · Paper page
Cited by
Deane, R., Bell, R., Sagare, A., & Zlokovic, B. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601867 · Cited by 548
Alzheimer disease models and human neuropathology: similarities and differences
Duyckaerts, C., Potier, M.-C., & Delatour, B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 375
Midkine and pleiotrophin in neural development and cancer
Kadomatsu, K., & Muramatsu, T. (2004) · Cancer Letters · doi:10.1016/s0304-3835(03)00450-6 · Cited by 354
Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297
Kanekiyo, T., & Bu, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00093 · Cited by 281
Metadata
- Authors
- Arélin, K., Kinoshita, A., Whelan, C. M., Irizarry, M. C., Rebeck, G. W., Strickland, D. K., & Hyman, B. T.
- Venue
- Molecular Brain Research
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 104
- Issue
- 1
- Pages
- 38-46
- ISSN
- 0169-328X
- Cited by
- 77
- References
- 15
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: LRP and senile plaques in Alzheimer’s disease: colocalization with apolipoprotein E and with activated astrocytes. https://app.cochat.ai/papers/10.1016/s0169-328x(02)00203-6
- The paper
- Arélin, K., Kinoshita, A., Whelan, C. M., Irizarry, M. C., Rebeck, G. W., Strickland, D. K., & Hyman, B. T. (2002). LRP and senile plaques in Alzheimer’s disease: colocalization with apolipoprotein E and with activated astrocytes. Molecular Brain Research. https://doi.org/10.1016/s0169-328x(02)00203-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.